|A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade|
DS Thommen, VH Koelzer, P Herzig, A Roller, M Trefny, S Dimeloe, ...
Nature medicine 24 (7), 994-1004, 2018
|Tumor budding in colorectal cancer—ready for diagnostic practice?|
VH Koelzer, I Zlobec, A Lugli
Human pathology 47 (1), 4-19, 2016
|Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study|
E Domingo, L Freeman-Mills, E Rayner, M Glaire, S Briggs, L Vermeulen, ...
The lancet Gastroenterology & hepatology 1 (3), 207-216, 2016
|Proposal for a 10-high-power-fields scoring method for the assessment of tumor budding in colorectal cancer|
E Karamitopoulou, I Zlobec, V Kölzer, A Kondi-Pafiti, ES Patsouris, ...
Modern pathology 26 (2), 295-301, 2013
|Tumor budding score based on 10 high-power fields is a promising basis for a standardized prognostic scoring system in stage II colorectal cancer|
M Horcic, VH Koelzer, E Karamitopoulou, L Terracciano, G Puppa, ...
Human pathology 44 (5), 697-705, 2013
|Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors—an autopsy study|
VH Koelzer, SI Rothschild, D Zihler, A Wicki, B Willi, N Willi, M Voegeli, ...
Journal for immunotherapy of cancer 4 (1), 1-8, 2016
|Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study|
VH Koelzer, I Zlobec, MD Berger, G Cathomas, H Dawson, K Dirschmid, ...
Virchows Archiv 466 (5), 485-493, 2015
|CD103 is a hallmark of tumor‐infiltrating regulatory T cells|
D Anz, W Mueller, M Golic, WG Kunz, M Rapp, VH Koelzer, J Ellermeier, ...
International journal of cancer 129 (10), 2417-2426, 2011
|Immunostimulatory RNA blocks suppression by regulatory T cells|
D Anz, VH Koelzer, S Moder, R Thaler, T Schwerd, K Lahl, T Sparwasser, ...
The journal of immunology 184 (2), 939-946, 2010
|Intratumoural budding (ITB) in preoperative biopsies predicts the presence of lymph node and distant metastases in colon and rectal cancer patients|
I Zlobec, M Hädrich, H Dawson, VH Koelzer, M Borner, M Mallaev, ...
British journal of cancer 110 (4), 1008-1013, 2014
|Phenotyping of tumor-associated macrophages in colorectal cancer: Impact on single cell invasion (tumor budding) and clinicopathological outcome|
VH Koelzer, K Canonica, H Dawson, L Sokol, ...
Oncoimmunology 5 (4), e1106677, 2016
|The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice|
KD Mertz, LF Mager, MH Wasmer, T Thiesler, VH Koelzer, G Ruzzante, ...
Oncoimmunology 5 (1), e1062966, 2016
|TWIST1 and TWIST2 promoter methylation and protein expression in tumor stroma influence the epithelial-mesenchymal transition-like tumor budding phenotype in colorectal cancer|
JA Galván, M Helbling, VH Koelzer, MP Tschan, MD Berger, M Hädrich, ...
Oncotarget 6 (2), 874, 2015
|CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival|
VH Koelzer, A Lugli, H Dawson, M Hädrich, MD Berger, M Borner, ...
Journal of translational medicine 12 (1), 81, 2014
|Next-generation tissue microarray (ngTMA) increases the quality of biomarker studies: an example using CD3, CD8, and CD45RO in the tumor microenvironment of six different solid …|
I Zlobec, VH Koelzer, H Dawson, A Perren, A Lugli
Journal of translational medicine 11 (1), 1-7, 2013
|Possible role of Cdx2 in the serrated pathway of colorectal cancer characterized by BRAF mutation, high‐level CpG Island methylator phenotype and mismatch repair‐deficiency|
H Dawson, JA Galván, M Helbling, DE Muller, E Karamitopoulou, ...
International journal of cancer 134 (10), 2342-2351, 2014
|The apoptotic and proliferation rate of tumour budding cells in colorectal cancer outlines a heterogeneous population of cells with various impacts on clinical outcome|
H Dawson, VH Koelzer, E Karamitopoulou, M Economou, C Hammer, ...
Histopathology 64 (4), 577-584, 2014
|The tumor border configuration of colorectal cancer as a histomorphological prognostic indicator|
VH Koelzer, A Lugli
Frontiers in oncology 4, 29, 2014
|Tumor-associated macrophages and response to 5-fluorouracil adjuvant therapy in stage III colorectal cancer|
A Malesci, P Bianchi, G Celesti, G Basso, F Marchesi, F Grizzi, G Di Caro, ...
Oncoimmunology 6 (12), e1342918, 2017
|Heterogeneity analysis of metastasis associated in colon cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study|
VH Koelzer, P Herrmann, I Zlobec, E Karamitopoulou, A Lugli, U Stein
BMC cancer 15 (1), 160, 2015